Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
about
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationImpact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas.HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy.Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsRNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Complex HuR function in pancreatic cancer cells.Posttranscriptional Regulation of PARG mRNA by HuR Facilitates DNA Repair and Resistance to PARP Inhibitors.Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.
P2860
Q28829561-85E74199-1924-458E-8AD0-967D66E3E6FDQ37687521-99B7FD79-6119-414B-AD6A-60F2B3B57ED4Q37718358-A6E3841F-788A-42E6-B38A-815FBE1B5E33Q40064209-A06F1FEC-03B4-4AE2-8676-D0AF515CF064Q40176991-4DEF1D32-8C12-46E3-A690-8436A07DBD23Q40996472-3C970FA6-4CDB-4636-81BA-2A3D76803D77Q42368968-0FB16876-BA40-4167-835B-B946223CABDBQ47129433-FBFD9DB3-C3A6-4784-8015-481CCE7E85B4Q47200415-728EC889-D579-455E-B62E-26D0F6271B2CQ48820342-E1C85AE7-D993-4DAE-B3F8-9A5830DDA5A1Q49922188-0172385E-A4FA-4092-8E28-07E337326037Q50902460-1E0C6BF9-FE07-4826-9166-7272AF325015Q52370800-871217AA-E90D-43DC-A550-9B7B3A159167Q55018323-542AEB75-6922-4B74-AFDD-358E8515CF19
P2860
Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@ast
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@en
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@nl
type
label
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@ast
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@en
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@nl
prefLabel
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@ast
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@en
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@nl
P2093
P1433
P1476
Delivery of Therapeutics Targe ...... ppresses Ovarian Tumor Growth.
@en
P2093
Gregory E Gonye
Jacquelyn Gerhart
Janet A Sawicki
Jonathan R Brody
Kelly Rhodes
Masaya Jimbo
Narumi Furuuchi
Robert C Getts
Weidan Peng
Yu-Hung Huang
P304
P356
10.1158/0008-5472.CAN-15-2073
P407
P577
2016-02-26T00:00:00Z